Skip to main content
Signal8
Launch Terminal

SYNLOGIC, INC. (SYBX)

Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Synlogic, Inc. logo

Synlogic, Inc.

OTC:SYBXHealthcare
+0.00%$1.05
Mkt Cap$12.86M
Float4.97M
O/S12.25M
Inst Own0.2%
SI0.1%
Dilution
Synlogic, Inc. logoOTC:SYBX$1.05+0.00%
FormDescription
4
Statement of Changes in Beneficial Ownership
10-Q
Quarterly Report
7
13D/A
Beneficial Ownership Report (Active, Amended)
13D/A
Beneficial Ownership Report (Active, Amended)
425
Business Combination Communication
4
8-K
1.01,3.03,5.01,7.01,9.01
4
25-NSE
SEC Filing
10-Q
Quarterly Report
5
10-K/A
Annual Report (Amended)
13D/A
Beneficial Ownership Report (Active, Amended)
10-K
Annual Report
8-K/A
3.01,8.01
13G
Beneficial Ownership Report
8-K
3.01
8-K
5.02,5.07,9.01
8-K
3.01
10-Q
Quarterly Report
13G/A
Beneficial Ownership Report (Amended)
ARS
SEC Filing
DEF 14A
Definitive Proxy Statement
4
Statement of Changes in Beneficial Ownership
EFFECT
Notice of Effectiveness
CORRESP
SEC Filing
S-3/A
Shelf Registration Statement (Amended)
UPLOAD
SEC Filing

1-25 of 625

…